Helen Pentikis

Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada.

Modis Therapeutics, Inc. is a biopharmaceutical company, which develops disease-modifying therapies for rare genetic diseases. Its product MT1621 is in clinical development for thymidine kinase 2 deficiency (TK2d), an inherited mitochondrial disease. The company was founded by Peter H. Barber and Daniel D. DiPietro in 2016 and is headquartered in Oakland, CA.

Meves Pharmaceuticals, Inc. provides pharmaceutical products and services. The company is headquartered in New York, NY.

Part of Fair Isaac Corp., Vertex Partners is a consulting firm based in Boston, MA. The company provides consulting services in various fields such as strategy/IT and recruiting. Vertex Partners combines the knowledge of many companies to create new ventures and supports initiatives related to innovation and new business creation. Luce, a recruitment firm, is a subsidiary of Vertex Partners. Accuchain, a company that modernizes HR recruitment software, is also a part of Vertex Partners. The company was founded by Paul J. Bascobert. Vertex Partners was acquired by Braun Consulting, Inc. on May 11, 1999.

Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Charm Therapeutics Ltd. is a British London-based company that is discovering and developing small molecule medicines using its proprietary 3D deep learning-enabled platform, Dragonfold. The company aims to create life-changing therapies for difficult-to-drug targets in cancer and other disease areas. Charm Therapeutics has raised $70 million to date and is supported by high-quality international investors, including Orbimed, F-Prime Capital, General Catalyst, Khosla Ventures, Bristol Myers Squibb, NVIDIA, and Grep-VC. The company was founded in 2021 by Laksh Aithani and David Baker, with Laksh Aithani serving as the CEO since then.

Aer Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Raleigh, NC. The company's mission is to advance the treatment paradigm for mucus mediated lung diseases. The company is dedicated to delivering a therapeutic solution to patients suffering from muco-obstructive lung diseases, with their initial focus being on chronic obstructive pulmonary disease (COPD) and other muco-obstructive lung diseases to follow, including asthma, cystic fibrosis, and primary ciliary. The company was founded by John Fahy, and the CEO is Jim Shaffer.

Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom.

Orbimed Private Investments VI LP seeks investment opportunities companies located in North America and Europe. The fund targets companies operating in the fields of biopharmaceutical, medical device, diagnostics and healthcare services. It provides financing for seed stage, early stage, and later stage companies for both public and private companies with an investment size of $10 million to $75 million.

EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA.

Pionyr Immunotherapeutics, Inc. develops cancer immunotherapies. It targets the tumor microenvironment to enhance the body?s antitumor immunity. The company was founded by Max Krummel and Sachdev Sidhu in 2015 and is headquartered in San Francisco, CA.

Attenua, Inc. engages in the provision of biopharmaceutical services. The company was founded by Jing Liang and is headquartered in San Mateo, CA.

Part of Lupin Ltd., Lupin Research, Inc. is a company that manufactures and commercializes pharmaceutical products. The company is based in Baltimore, MD.

Synchem Properties Pvt Ltd. is an Indian company that leases and manages real estate properties. The private company was founded in 2015. The company is based in Mumbai, India.

Part of Lupin Ltd., Lupin Atlantis Holdings SA is a holding Swiss company that manufactures and distributes pharmaceutical products. The company is based in Zug, Switzerland.

Novel Laboratories, Inc. manufactures and sells compressors. It also provides development and manufacturing services for other pharmaceutical research-based and generic pharmaceutical companies. The firm specializes in the development and manufacture of orally-disintegrating, liquid, modified-release, powder, and rectal dosage forms; immediate-release and chewable tablets, immediate-release and modified-release capsules, semi-solids, rectal gels, and rectal suppositories. The company was founded by Veerappan Sellappan Subramanian in December 2006 and is headquartered in Somerset, NJ.

Part of Lupin Ltd., Lupin, Inc. is a pharmaceutical company. The company is based in Baltimore, MD.

Lupin GmbH provides management services. The private company is based in Schaffhausen, Switzerland. The CEO of the Swiss company is Vinita Deshbandhu Gupta.

Kyowa Pharmaceutical Industry Co., Ltd. develops, manufactures, and markets pharmaceutical products. It offers tranquilizers, hypnotics, vasodilators, bronchial dilators, and anti-ulcer agents. The company was founded on January 29, 1954 and is headquartered in Osaka, Japan.

Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA.

Lupin Pharmaceuticals, Inc. provides pharmaceutical products healthcare professionals and patients across geographies. The firm offers generic, specialty and active pharmaceutical ingredient drugs for diabetic, anti-inflammatory and respiratory therapy. The company was founded in 2003 and is headquartered in Baltimore, MD.

Zyngenia, Inc. developed new class of bio-therapeutics. The company was founded by Joseph L. Amprey III, Carlos F. Barbas III and Peter Alec Kiener in 2008 and headquartered in Gaithersburg, MD.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.